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OBJECTIVES We sought to investigate whether a brief episode of myocardial ischemia produces a
detectable cardiac oxidative stress in patients undergoing elective coronary angioplasty
(PTCA).
BACKGROUND Although cardiac oxidative stress has been clearly demonstrated in experimental models of
ischemia-reperfusion, its presence in patients after transient myocardial ischemia is still
unclear.
METHODS In order to evaluate oxidative stress in ischemic cardiac regions, plasma conjugated dienes
(CD), lipid hydroperoxides (ROOHs) and total antioxidant capacity (TRAP), independent
indexes of oxidative stress, were measured in the aorta and great cardiac vein (GCV) before
(t0), 1, (t1), 5 (t5) and 15 min (t15) after first balloon inflation in 15 patients undergoing
PTCA on left anterior descending coronary artery (Group 1); six patients with right coronary
artery stenosis (Group 2), which is not drained by the GCV, were studied as controls.
RESULTS In Group 1 at baseline, CD and ROOHs levels were higher in GCV than in aorta (p , 0.01
for both), and TRAP levels were lower (p , 0.01). Aortic levels of CD, ROOHs and TRAP
did not change at any time after t0; venous levels of CD and ROOHs levels markedly
increased at t1, at t5 and remained elevated at t15 (p , 0.01 for all comparisons vs. t0); venous
levels of TRAP decreased at t1 and t5 (p , 0.01 vs. t0) and returned to normal at t15. In
Group 2, CD, ROOHs and TRAP levels were similar in the aorta and GCV and did not
change throughout the study.
CONCLUSIONS Short episodes of myocardial ischemia during PTCA induce a sustained oxidative stress,
which is detectable in the venous effluent of reperfused myocardium. (J Am Coll Cardiol
2000;35:633–9) © 2000 by the American College of Cardiology
Lipid peroxidation of membrane polyunsaturated fatty acids
by reactive oxygen species (ROS) is considered the major
mechanism of ischemia-reperfusion injury (1). An enhanced
cardiac oxidative stress has consistently been demonstrated
in experimental ischemia-reperfusion models (2,3) and after
severe myocardial ischemia in patients with acute myocar-
dial infarction (4–6) or during extracorporeal circulation
(7,8); however, its presence in patients undergoing brief
episodes of myocardial ischemia is still controversial (9–15),
partially because of the intrinsic limitations in the available
methods of in vivo measurement. Since direct assessment of
ROS (2,3) is not applicable in humans, plasma levels of lipid
peroxidation products and of antioxidants are the most
commonly investigated markers of oxidative stress in clinical
studies (16–19). Conjugated dienes (CD) and lipid hy-
droperoxides (ROOHs) are two independent and stable
indexes of in vivo ROS production (18,19); they are
generated at intermediate stages of lipid peroxidation cas-
cade and are considered to be more specific than other
oxidative products, such as malondialdehyde (18 –20).
Plasma antioxidant capacity (TRAP) is an accurate index of
oxidative stress, which provides a measure of total plasma
defenses against ROS (21).
Therefore, in order to investigate cardiac oxidative stress
and its response to transient episodes of myocardial isch-
emia, we measured levels of CD, ROOHs and TRAP in the
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coronary circulation of anginal patients undergoing elective
percutaneous transluminal coronary angioplasty (PTCA), a
clinical model of controlled ischemia-reperfusion.
METHODS
Patients. Twenty-one patients with a single, discrete cor-
onary stenosis undergoing elective PTCA were studied
(Table 1): 15 had a proximal stenosis of the left anterior
descending coronary artery (LAD) (Group 1) and six had a
proximal stenosis of the right coronary artery (RCA)
(Group 2). Patients with angina episodes in the last 12 h
before the procedure, myocardial infarction in the last three
months, complex or severe (.90%) coronary stenosis, an-
giographically detectable collateral circulation or intercur-
rent inflammatory process were excluded. At the time of
PTCA, all patients were on oral aspirin; 17 patients were on
oral calcium-antagonists, 12 on oral nitrates and 9 on
beta-adrenergic blocking agents. No patient was on vita-
mins.
The protocol was approved by the Ethics Committee of
the Catholic University of Rome; all patients gave informed
consent.
Protocol. In a fasting state, a coronary guiding catheter was
advanced in the aorta, and it was utilized to perform PTCA
and arterial sampling; a multipurpose catheter was posi-
tioned, through femoral access, into the great cardiac vein
(GCV). As the GCV selectively drains blood from left
coronary territory only, in Group 1 patients, who had
PTCA on LAD, blood samples were collected from the
cardiac regions undergoing ischemia-reperfusion; con-
versely, in Group 2 patients, who had PTCA on the RCA,
venous blood was collected from cardiac regions that were
not jeopardized by ischemia-reperfusion. Six Group 1 and
all six Group 2 patients underwent aorta and GCV sam-
pling before the first balloon inflation (t0) and at 1 (t1), 5 (t5)
and 15 min (t15) after first balloon deflation. In the
remaining nine Group 1 patients, blood samples were
collected at t0 from the aorta and GCV, and at t1, t5 and t15
from the GCV only. Blood was collected in heparinized
syringes for measurement of oxygen saturation and for
extraction of plasma, which was stored at 270° and used
within one month. Arterial blood pressure, heart rate and
three ECG leads were continuously monitored throughout
the study. Endovenous heparin was given at baseline (100
U/kg) and throughout PTCA in order maintain the acti-
vated coagulation time $300 s. Anginal pain (scored from 0
to 10) and maximal ST segment shift were regarded as
indexes of balloon induced ischemia and the increase of
oxygen saturation in the GCV as a marker of postischemic
reactive hyperemia.
Abbreviations and Acronyms
A.U. 5 arbitrary units
CD 5 conjugated dienes
GCV 5 great cardiac vein
LAD 5 left anterior descending coronary artery
PTCA 5 percutaneous transluminal coronary
angioplasty
RCA 5 right coronary artery
ROOHs 5 hydroperoxides
ROS 5 reactive oxygen species
TRAP 5 plasma antioxidant capacity
t0 5 before first balloon inflation
t1 5 1 min after first balloon deflation
t5 5 5 min after first balloon deflation
t15 5 15 min after first balloon deflation
Table 1. Clinical and Procedural Characteristics
Group 1
15 Patients
(%)
Group 2
6 Patients
(%)
p
Value
Age (yr) 63 6 9 62 6 8 NS
Men (n) 13 (87) 3 (50) NS
Diabetes (n) 3 (20) 1 (17) NS
Hypertension (n) 8 (53) 2 (33) NS
Cigarette smoking (n) 2 (13) 1 (17) NS
Plasma cholesterol .200 mg/dl (n) 6 (40) 2 (33) NS
Previous MI (n) 6 (40) 3 (50) NS
Stable/unstable angina (n) 8/7 3/3 NS
CCS I–II/III–IV (n) 6/2 1/2 NS
Braunwald classification IB/II–IIIB (n) 0/7 0/3 NS
Diameter stenosis (%) 80 6 9 78 6 4 NS
Duration of first balloon inflation (s) 111 6 43 156 6 35 NS
ST-segment shift (mm) 1.3 6 0.8 0.9 6 0.7 NS
Angina score (from 0 to 10) 6 6 4 5 6 4 NS
CCS 5 Canadian Cardiovascular Society classification of angina; MI 5 myocardial infarction; n 5 number; NS 5 not
significant.
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Measurement of lipid peroxidation products. Plasma lip-
ids were extracted by a modification of the Folch method
(22). Conjugated dienes (CD) were measured by second
derivative spectrophotometry (18). Minima at 232 nm and
246 nm were ascribed to the trans-trans and cis-trans
conjugated dienes isomers, respectively, and quantified in
arbitrary units as d2A/d lambda2, which represent the
measurement from minima to adjacent maxima at the
higher wavelength. Intra- and interassay coefficients of
variation for this method were 7.5% and 10.2%, respectively.
Hydroperoxides were measured with the FOX Version II
assay for lipid ROOHs (19). They were determined as a
function of the mean absorbance difference of samples with
and without elimination of ROOHs by triphenylphosphine.
Intra- and interassay coefficients of variation for this method
were 5.0% and 7.5%, respectively.
Measurements of plasma antioxidant capacity. Plasma
levels of TRAP were measured by the assay previously
described by Rice-Evans and Miller (21), which is based on
the quenching of the 2,29-azino-bis(3-ethylbenzthiazoline-
6-sulfonic acid [ABTS]) (Sigma, St. Louis, Missouri) rad-
ical cation by antioxidants. ABTS radical cation formation
was continuously monitored by absorbance increase at
734 nm, at 20° C. The assay was standardized using Trolox
(Fluka Chemie, Buchs, Switzerland), a water soluble vita-
min E analog. Intra- and interassay coefficients of variation
for this method were 7.5% and 9.1%, respectively.
Statistics. Levels of CD, ROOHs and TRAP and their
venous-arterial differences were normally distributed and are
expressed as mean 6 SD. Arterial and venous levels of CD,
ROOHs and TRAP and their venous-arterial differences at
different time-points were compared by analysis of variance,
and for a p , 0.05 comparisons were carried out using t test
with Bonferroni correction. Analysis of variance and t test
with Bonferroni correction was also used to compare oxygen
saturation in the GCV. Linear regression analysis was used
to define the relationship between indexes of ischemia and
markers of peroxidation. A p value ,0.05 (two-tailed) was
considered significant.
RESULTS
Clinical and procedural characteristics were not different in
the two groups of patients (Table 1).
Blood oxygen saturation. In Group 1, undergoing PTCA
on the LAD, oxygen saturation in the GCV was unchanged
immediately before balloon deflation (30.1 6 8.6% vs.
28.0 6 5.5% at t0, p 5 NS) but increased markedly at t1
(49.3 6 7.8%, p , 0.01 vs. t0), demonstrating postischemic
reactive hyperemia; conversely, no significant change was
observed in Group 2, undergoing PTCA on the RCA
(29.4 6 5.0 at t1 vs. 30 6 4.0 at t0, p 5 NS) (Fig. 1).
Lipid peroxidation at baseline. In Group 1 patients, CD
and ROOHs at t0 were significantly higher in the GCV
than in the aorta (0.035 6 0.001 vs. 0.031 6 0.002 arbitrary
units [A.U.], p , 0.01 and 3.41 6 0.9 vs. 2.35 6 0.03
mmol/l, p , 0.01, respectively), while TRAP was lower
(809 6 52 vs. 952 6 66 mmol/l, p , 0.01); conversely, in
Group 2 patients, CD (0.036 6 0.004 vs. 0.035 6 0.004
A.U.), ROOHs (3.26 6 0.80 vs. 2.58 6 0.82 mmol/l) and
TRAP levels (904 6 112 vs. 989 6 35 mmol/l, P 5 NS) at
t0 were similar in the GCV and aorta.
Lipid peroxidation after ischemia-reperfusion. Group 1
patients. In the six Group 1 patients, who had blood
sampling in both the aorta and GCV at all time-points,
arterial levels of CD, ROOHs and TRAP did not change at
Figure 1. The graphs refer to the six Group 1 and six Group 2
patients in whom paired blood samples from great cardiac vein
(GCV) and aorta were obtained throughout the study. Blood
oxygen saturation (sO2) significantly increased in the GCV 1 min
after balloon deflation (t1) compared with baseline (t0); no increase
was observed in Group 2 patients. In Group 1 patients, differences
between concentration of conjugated dienes (CD) in GCV and
aorta (delta CD) consistently increased 1 (t1) and 5 min (t5) after
balloon deflation and were still elevated at 15 min (t15) compared
with t0; differences between concentration of hydroperoxides
(ROOHs) in GCV and aorta (delta ROOHs) showed similar
changes. In Group 2 patients, delta CD and delta ROOHs did not
change throughout the study. Differences between plasma antiox-
idant capacity (TRAP) values in GCV and aorta (delta TRAP) did
not change at t1, t5 and t15 in both groups. Thick lines represent
mean values; dashed lines represent individual data. *p , 0.01 vs.
baseline.
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any time-point after t0 (p 5 NS at each time-point vs. t0 for
both CD, ROOHs and TRAP). In the same patients,
venous levels of CD and ROOHs markedly increased at t1
and at t5 and remained elevated at t15 (p , 0.01 at each
time-point vs. t0, for both CD and ROOHs); TRAP
significantly decreased at t1 (p , 0.05 vs. t0), and t5 (p ,
0.05 vs. t0) and returned to baseline at t15 (p 5 NS vs. t0)
(Fig. 2A). Similar changes of CD, ROOHs and TRAP
were observed in the GCV in the remaining nine Group 1
patients, who had venous but not arterial sampling follow-
ing t0 (Fig. 2B). In all Group 1 patients, although both
venous levels of cis-trans and trans-trans CD increased after
balloon deflation, cis-trans CD showed a larger increase
(peak increase 386 6 127% vs. t0) than trans-trans CD
(30 6 15% vs. t0; p , 0.01 vs. cis-trans CD increase) (Fig.
2). In the same patients, the peak increases in the GCV of
total CD (r 5 20.83, p , 0.001), cis-trans CD (r 5 20.90,
p , 0.001), trans-trans CD (r 5 20.75, p 5 0.001) and
ROOHs (r 5 20.92, p , 0.001) were inversely correlated
with their baseline levels; conversely, they were not related
to severity of angina, ST segment shift or reactive hyperemia
(Fig. 3).
In the six Group 1 patients, who had blood sampling in
both the aorta and GCV at all time-points, venous-arterial
differences of CD significantly increased at t1 (p , 0.01)
and at t5 (p , 0.01 vs. t0) and remained elevated at t15 (p ,
0.01 vs. t0) (Fig. 1); venous-arterial differences of cis-trans
CD markedly increased at t1 and t5, and they remained
elevated at t15, (p , 0.01 at each time-point vs. t0), whereas
a milder increase of venous-arterial differences of trans-trans
CD was observed at t1 (p 5 NS vs. t0) and t5 (p , 0.05 vs.
t0). Venous-arterial differences of ROOHs showed similar
changes (p , 0.01 at each time-point vs. t0) (Fig. 1).
Venous-arterial differences of TRAP mildly decreased at t1
and t5 without achieving statistical significance (Fig. 1).
Group 2 patients. Aortic and venous levels of CD,
ROOHs and TRAP were remarkably stable at all time-
points following t0 (p 5 NS at each time-point vs. t0 for
both arterial and venous CD, ROOHs and TRAP levels)
(Fig. 4). In the same group of patients, venous-arterial
Figure 2. Levels of cis-trans conjugated dienes (CD), trans-trans CD, hydroperoxides (ROOHs) and total antioxidant capacity (TRAP)
in the six Group 1 patients in whom blood samples were obtained from GCV and aorta (A) and in the nine Group 1 patients sampled
from GCV only but not from aorta (B). Venous levels of CD isomers and ROOHs markedly increased and TRAP values decreased 1 (t1)
and 5 (t5) min after balloon deflation; levels of CD isomers and ROOHs were still elevated, whereas TRAP values returned to baseline
levels 15 min after balloon deflation (t15). No changes of CD, ROOHs or TRAP levels were observed in aorta. Thick lines represent mean
values; dashed lines represent individual data. *p , 0.01 vs. baseline. †p , 0.05 vs. baseline.
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differences of CD, ROOHs and TRAP did not change at
any time (Fig. 1).
DISCUSSION
In our study, the use of three independent markers of
oxidative stress and selective GCV sampling allowed us to
demonstrate a marked and sustained cardiac oxidative stress
after short episodes of ischemia-reperfusion in anginal
patients undergoing elective PTCA on the LAD. Con-
versely, no transcardiac changes of oxidative stress markers
were observed in the GCV of patients undergoing PTCA of
the RCA. The presence of reactive hyperemia (assessed by
measuring sO2 in the GCV) in patients who underwent
PTCA of the LAD, but not in those who underwent PTCA
of the RCA, confirmed that the catheter tip was correctly
positioned in the GCV, which selectively drains blood from
myocardial regions perfused by the LAD. Therefore, a brief
episode of myocardial ischemia caused a marked oxidative
stress in the coronary circulation of ischemic regions, but
not in normal myocardial regions nor in the systemic
circulation.
Detection of oxidative stress in humans. Previous studies
showed absence of (13–15), or mild, oxidative stress (6,9–
12) after transient episodes of ischemia-reperfusion, proba-
bly because of low sensitivity and specificity of the assays
(5,9–15) and of peripheral blood sampling (14,15).
Direct measurement of oxygen free-radical generation by
electron spin resonance is accurate in animal models (2,3),
but it is not applicable in humans; therefore, ex vivo
spin-trapping techniques have been utilized in clinical
studies (4), but they are limited by the ex vivo production of
secondary oxidative species. Malondialdehyde, an end prod-
uct of lipid peroxidation, has been largely investigated by the
thiobarbituric acid assay, which is now questioned because it
underestimates the extent of lipid peroxidation and has a limited specificity (20). Isoprostanes are free-radical cata-
lyzed products of arachidonic acid, and they have been
recently proposed as noninvasive markers of in vivo oxida-
tive stress (5,6,17). Their urinary levels show a sharp
increase in patients with acute myocardial infarction a few
hours after reperfusion, either by thrombolysis or primary
PTCA (5,6). Yet only a mild increase (20% to 30%) was
observed in anginal patients 6 h after diagnostic coronary
arteriography and elective PTCA (6). Of note, in our study,
markers of oxidative stress increased by 80% to 230% in the
GCV after a single, brief balloon inflation. Therefore,
although isoprostanes are attractive noninvasive markers,
their accuracy is insufficient to detect the oxidative stress
resulting from brief episodes of myocardial ischemia in
humans. To this purpose, a selective cardiac blood sampling
is necessary in order to avoid false negative results (14,15);
indeed, lipoperoxide levels were remarkably stable through-
out the study, both in the aorta and in the venous blood of
nonischemic cardiac regions, suggesting that, in such a
clinical setting, peroxidative products were promptly diluted
and scavenged in the peripheral circulation.
Figure 3. Simple linear regression analysis of the relationship
between: (A) maximum increase of conjugated dienes (CD) and
their baseline levels in the GCV (r 5 20.83, p , 0.001); (B)
maximum increase of hydroperoxides (ROOHs) and their baseline
levels in the GCV (r 5 20.92, p , 0.001).
Figure 4. Levels of cis-trans conjugated dienes (CD), trans-trans
CD, hydroperoxides (ROOHs) and total antioxidant capacity
(TRAP) in the blood samples from aorta and great cardiac vein
(GCV) of six Group 2 patients. Levels of CD isomers, ROOHs
and TRAP did not change at 1 (t1), 5 (t5) nor 15 min (t15) after
balloon deflation, both in aorta and GCV. Thick lines represent
mean values; dashed lines represent individual data.
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In our study we chose two accurate methods for measur-
ing lipid peroxide generation (18,19). Second derivative
spectroscopy for CD determination provides greater sensi-
tivity compared with simple absorption spectroscopy and
gives additional information on the redox status as it
discriminates between two different CD configurations
(e.g., cis-trans and trans-trans); cis-trans CD are formed in
the presence of adequate levels of antioxidants; conversely,
with low antioxidant levels, the kinetic equilibrium of
oxidation is shifted towards trans-trans isomers, indexes of
irreversible oxidative damage (18). The FOX Version II
assay outperforms other assays for ROOHs assessment for
its simplicity and reproducibility, providing a measurement
of all classes of hydroperoxides in plasma (19).
Previous studies evaluated changes of single antioxidants
during PTCA with conflicting results (10,14); TRAP is
more likely to represent the real status of plasma defenses, as
it is largely determined by the overall effect of water-soluble
antioxidants (uric acid, ascorbic acid, protein thiols and
bilirubin) and lipid-soluble antioxidants (alpha-tocopherol,
beta-carotene, ubiquinol) (21).
Mechanisms of lipid peroxide generation after myocar-
dial ischemia-reperfusion. Our results consistently dem-
onstrated a marked and sustained increase of lipid peroxi-
dation and a transient decrease of antioxidant defenses,
which selectively affected the cardiac regions undergoing
transient episodes of ischemia-reperfusion. The simulta-
neous increase of oxygen saturation and of peroxidative
markers in GCV, peaking 1 min after balloon deflation,
suggested a ROS-mediated oxidative stress caused by sud-
den reoxygenation of a previous ischemic tissue (2). Both
CD isomers consistently increased in the GCV; however,
the larger increase of cis-trans CD isomers compared with
that of trans-trans isomers suggested that a single, brief
episode of ischemia-reperfusion generated a marked but
reversible oxidative injury. The simultaneous reduction of
TRAP values and the increase of ROOHs levels further
support a reperfusion-mediated oxidative stress; indeed,
ROOHs are generated, following CD formation, by oxygen
incorporation and further propagation of lipoperoxidative
reactions (19).
Timing of lipid peroxide generation in our study is similar
to that reported by previous studies in a similar clinical
setting with a peak lipid peroxide production between 1 and
5 min after reperfusion (3,10–12). However, we observed a
sustained release of both CD and ROOHs up to 15 min
after balloon deflation, rather than a return to baseline
levels, as reported by previous studies. This result may be
explained by longer balloon inflation (111 6 43 s instead of
the 60 s reported in previous studies) or a higher sensitivity
of our markers of oxidative stress (18–20). Mitochondrial
respiratory chain and endothelial xanthine oxidase are the
most likely metabolic pathways of ROS generation after
brief episodes of myocardial ischemia-reperfusion. Acti-
vated neutrophils can also contribute to ROS generation
(23); platelet derived ROS have been recently demonstrated
in vitro after 30 min of anoxia-reperfusion (24). However, at
least in our clinical model of a single, 2 min episode of
ischemia-reperfusion, both platelets and neutrophils are
unlikely to play a major role, as experimental studies have
shown that longer anoxic-reoxygenation periods are needed
in order to release detectable amounts of ROS by these cell
types (24,25). Further clinical studies are warranted in order
to clarify the relative contribution of these potential sources
of ROS following in vivo brief episodes of ischemia-
reperfusion.
Oxidative stress at baseline. We also observed a slight but
significant cardiac release of lipoperoxides and a reduced
plasma antioxidant capacity at baseline, in the coronary
circulation containing coronary stenosis (Group 1 patients),
in the absence of clinical evidences of recent episodes of
myocardial ischemia (last 12 h). The mechanisms respon-
sible for this mild baseline transcardiac production of
lipoperoxides cannot be deduced from the results of our
study. However, the absence of a transcardiac oxidative
stress at baseline in normal cardiac regions suggested that
repeated ischemia-reperfusion episodes and/or the athero-
sclerotic process may cause a persistent enhancement of
ROS generation by locally activated vascular cells (26,27).
Of note, this baseline oxidative stress was inversely
correlated with the peak increase of CD and ROOHs after
balloon deflation. This result is consistent with recent
experimental studies showing that an enhanced oxidative
stress contributes to cardiac protection from further oxida-
tive injury through an up-regulation of cellular antioxidant
enzymes (28,29). However, baseline levels of TRAP were
not related to the increase of lipoperoxides, probably be-
cause they mainly reflect plasma content of chain-breaking
antioxidants instead of the cellular content of inducible
enzymatic defenses (10,21).
Conclusions. Plasma levels of CD, ROOHs and TRAP
represent sensitive markers of cardiac oxidative stress in
humans. A baseline oxidative stress is detectable only in
venous blood draining the stenosed vessel. Short episodes of
myocardial ischemia induced a consistent and sustained
lipid peroxidation, which is detectable in the venous effluent
of reperfused myocardium. These findings suggest that
cardiac lipoperoxidation may be a common event following
brief episodes of myocardial ischemia and support a role for
antioxidant therapy in patients with ischemic heart disease.
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